Volume 2, Issue 3: Beyond Basal Insulin: GLP-1 Receptor Agonists in Combination
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 2, Issue 3)
Nurses and health care professionals involved in the care of patients with diabetes.
After participating in this activity, the participant will demonstrate the ability to describe new findings in:
- Describe the glucose lowering effects of GLP-1 receptor agonists when added to basal insulin.
- Summarize safety concerns with the use of insulin/GLP-1 receptor agonist combinations.
- Identify the physiologic differences in lowering post-prandial glucose between continuous and intermittent GLP-1 receptor agonists.
- 0.50 ANCC
- 0.50 Attendance